Biologics can provide opportunity for identifying a treatment or cure in cases of rare disease. BBCR team experience in biologics for rare diseases included rare cancers and precision medicine can help develop a targeted strategy including studies with fewer patients that control for safety issues.

BBCR team experience in biologics for rare diseases included rare cancers and precision medicine can help develop a targeted strategy including studies with fewer patients that control for safety issues.

• Indications analysis and prioritization
• Strategic drug assessment
• Clinical study design and protocol
• Biomarker strategy
• Early Clinical Development
• FDA meeting and submission
• Pre-ND integrated development plan
• CRO and project management
• Study remediation and rescue

Contact BBCR to get started

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

URL

This field is for validation purposes and should be left unchanged.

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA